Return to search results
Oxycodone
XTAMPZA ER is an extended-release oral capsule containing oxycodone, a prescription opioid agonist used for pain management. Available in strengths from 9 mg to 36 mg, it's manufactured by Collegium Pharmaceutical, Inc., and classified as a DEA Schedule II controlled substance. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[ "009:10" ] |
| contactPoint |
{ "fn": "Division of Drug Information", "@type": "vcard:Contact", "hasEmail": "mailto:druginfo@fda.hhs.gov" } |
| description | XTAMPZA ER is an extended-release oral capsule containing oxycodone, a prescription opioid agonist used for pain management. Available in strengths from 9 mg to 36 mg, it's manufactured by Collegium Pharmaceutical, Inc., and classified as a DEA Schedule II controlled substance. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[ { "@type": "dcat:Distribution", "title": "Oxycodone", "mediaType": "text/html", "description": " Access the FDA dataset for Oxycodone — ANDA 207418 submitted by Mylan Institutional LLC ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207418" } ] |
| identifier | ANDA207418 |
| issued | 2016-09-16 |
| keyword |
[ "drug", "drug-information", "drug-manufacturers", "pharmaceuticals", "prescription-drugs" ] |
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[ "009:002" ] |
| publisher |
{ "name": "U.S. Food and Drug Administration", "@type": "org:Organization" } |
| theme |
[ "FDA" ] |
| title | Oxycodone |
